We are live on
!
Find out more
MB
MPM BioImpact Portfolio holdings
AUM
$1.29B
1-Year Est. Return
141.72%
This Fund
S&P 500
This Quarter
Est. Return
+44.98%
1 Year Est. Return
+141.72%
3 Year Est. Return
+440.65%
5 Year Est. Return
+290.21%
10 Year Est. Return
–
AUM
$874M
AUM Growth
+$263M
(+43%)
Cap. Flow
+$99.1M
Cap. Flow
% of AUM
11.34%
Top 10 Holdings %
Top 10 Hldgs %
49.85%
Holding
55
New
15
Increased
6
Reduced
16
Closed
17
Top Buys
| 1 |
uniQure
QURE
|
+$53.3M |
| 2 |
Agios Pharmaceuticals
AGIO
|
+$45.7M |
| 3 |
Liquidia Corp
LQDA
|
+$34.2M |
| 4 |
Corvus Pharmaceuticals
CRVS
|
+$21.6M |
| 5 |
UroGen Pharma
URGN
|
+$17.5M |
Top Sells
| 1 |
RNAM
Avidity Biosciences
RNAM
|
+$33.1M |
| 2 |
Zai Lab
ZLAB
|
+$25.3M |
| 3 |
Compass Therapeutics
CMPX
|
+$17.8M |
| 4 |
Alkermes
ALKS
|
+$16.5M |
| 5 |
Vera Therapeutics
VERA
|
+$16.4M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Context Therapeutics
CNTX
$57.3M
| $15.7M | 1.8% |
10,679,391
-4,026,491
| -27% | -$4.7M |
|
27
Arcutis Biotherapeutics
ARQT
$3.45B
| $15.4M | 1.77% |
+531,200
| New | +$13.6M |
|
|
VTYX
28
DELISTED
Ventyx Biosciences
VTYX
| $14.8M | 1.69% |
+1,639,061
| New | +$12.2M |
|
29
Oric Pharmaceuticals
ORIC
$1.17B
| $14.7M | 1.68% |
1,798,717
+69,339
| +4% | +$798K |
|
|
BLTE
30
Belite Bio
BLTE
$6B
| $14M | 1.61% |
+87,760
| New | +$10.4M |
|
|
RAPT
31
DELISTED
RAPT Therapeutics
RAPT
| $13.5M | 1.54% |
+397,906
| New | +$12.4M |
|
|
CLYM
32
Climb Bio
CLYM
$780M
| $10.7M | 1.22% |
+2,671,480
| New | +$6.42M |
|
|
ABVX
33
Abivax
ABVX
$11.9B
| $7.59M | 0.87% |
+56,316
| New | +$6.14M |
|
34
Rocket Pharmaceuticals
RCKT
$400M
| $5.57M | 0.64% |
1,586,076
-2,317,305
| -59% | -$7.93M |
|
|
MAZE
35
Maze Therapeutics
MAZE
$1.61B
| $3.36M | 0.38% |
+81,145
| New | +$2.79M |
|
|
EVMN
36
Evommune Inc
EVMN
$447M
| $1.93M | 0.22% |
+113,022
| New | +$2.12M |
|
37
Sarepta Therapeutics
SRPT
$1.85B
| $1.51M | 0.17% |
70,000
-630,000
| -90% | -$13.3M |
|
38
Werewolf Therapeutics
HOWL
$16.8M
| $884K | 0.1% |
1,393,557
-1,015,253
| -42% | -$1.23M |
|
39
Akebia Therapeutics
AKBA
$370M
| – | – |
-2,889,125
| Closed | -$7.89M |
|
|
40
Alkermes
ALKS
$8.65B
| – | – |
-549,262
| Closed | -$16.5M |
|
41
Assembly Biosciences
ASMB
$530M
| – | – |
-39,665
| Closed | -$1.02M |
|
|
42
Compass Therapeutics
CMPX
$387M
| – | – |
-5,075,970
| Closed | -$17.8M |
|
43
Design Therapeutics
DSGN
$841M
| – | – |
-555,187
| Closed | -$4.18M |
|
44
Janux Therapeutics
JANX
$971M
| – | – |
-614,282
| Closed | -$15M |
|
45
Ultragenyx Pharmaceutical
RARE
$3.11B
| – | – |
-395,700
| Closed | -$11.9M |
|
|
RNAM
46
DELISTED
Avidity Biosciences
RNAM
| – | – |
-760,022
| Closed | -$33.1M |
|
47
Cartesian Therapeutics
RNAC
$250M
| – | – |
-380,000
| Closed | -$3.88M |
|
|
RPTX
48
DELISTED
Repare Therapeutics
RPTX
| – | – |
-819,924
| Closed | -$1.44M |
|
49
Solid Biosciences
SLDB
$939M
| – | – |
-1,634,569
| Closed | -$10.1M |
|
|
SLNO
50
DELISTED
Soleno Therapeutics
SLNO
| – | – |
-150,000
| Closed | -$10.1M |
|
Similar funds
MCM
PWP
ACM
GPCM
ACM
PCM
COCM
MA